Edward J. Sitar, Chief Financial Officer at CANCER GENETICS, INC (CGIX), bought 1,000 shares at $6.99 ($7K) on 2015-03-16, disclosed to the SEC on 2015-03-18.
Open-market purchase of $7k CGIX by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| NMTR | BUY | 2021-04-06 | $50K | — | Filing → |
| NMTR | BUY | 2020-12-17 | $40K | — | Filing → |
| CGIX | SELL | 2016-11-16 | $5K | — | Filing → |